VAERS reports by lot

GSK DTaP/Tdap lot H4279: VAERS reports

24 VAERS reports list lot H4279 as a GSK DTaP/Tdap vaccine, received between 2025-06-23 and 2026-04-02. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
4%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1828%
Injection-site / Local reaction1828%
Dermatological (non-injection-site)812%
General / Systemic (non-local)711%
Cardiac / Cardiovascular69%
Gastrointestinal35%
Musculoskeletal35%
Psychiatric / Neuropsychiatric23%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Michigan3
Florida3
California3
New York2
Ohio2
Georgia2
Illinois1
Texas1
Mississippi1
North Carolina1
South Carolina1
Massachusetts1

Reports by month received

MonthReportsBar
2025-063
2025-0711
2025-087
2025-091
2025-101
2026-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): GC5NG · GG39D · H242K · H4K3S · H99J7 · H9FM5

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.